Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Lopez

Showing results (421-430 of 459) with videos related to

Pageof 46
Sort By:
Journal of Neurology|February 8, 2020
Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
Journal of Neurology|January 5, 2021
Correction to: Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
British Journal of Cancer|October 16, 2018
D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosisLuis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, et al.
Journal of Huntington'S Disease|October 4, 2021
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's DiseaseAndrea Horta-Barba, Saul Martinez-Horta, Jesús Perez-Perez, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 10, 2018
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American CountriesRoberto José Pessoa de Magalhães Filho, Edvan Crusoe, Eloisa Riva, et al.
Cell Host & Microbe|May 17, 2023
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individualsMathieu Hubert, Florence Guivel-Benhassine, Timothée Bruel, et al.
Chest|January 23, 2015
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPDCiro Casanova, Jose M Marin, Cristina Martinez-Gonzalez, et al.
Journal of Neurology|July 18, 2023
Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instrumentsAndrea Horta-Barba, Saul Martinez-Horta, Jesús Pérez-Pérez, et al.
Circulation|September 1, 2020
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA TrialRenato D Lopes, Karen P Alexander, Susanna R Stevens, et al.
Chest|February 14, 2014
Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohortJuan P de Torres, Jose M Marin, Cristina Martinez-Gonzalez, et al.
Pageof 46

Showing results (421-430 of 459) with videos related to

Sort By:
Pageof 46
Journal of Neurology|February 8, 2020
Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
Journal of Neurology|January 5, 2021
Correction to: Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's diseaseSaul Martinez-Horta, Andrea Horta-Barba, Jesús Perez-Perez, et al.
British Journal of Cancer|October 16, 2018
D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosisLuis Jara-Palomares, Aurora Solier-Lopez, Teresa Elias-Hernandez, et al.
Journal of Huntington'S Disease|October 4, 2021
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's DiseaseAndrea Horta-Barba, Saul Martinez-Horta, Jesús Perez-Perez, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 10, 2018
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American CountriesRoberto José Pessoa de Magalhães Filho, Edvan Crusoe, Eloisa Riva, et al.
Cell Host & Microbe|May 17, 2023
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individualsMathieu Hubert, Florence Guivel-Benhassine, Timothée Bruel, et al.
Chest|January 23, 2015
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPDCiro Casanova, Jose M Marin, Cristina Martinez-Gonzalez, et al.
Journal of Neurology|July 18, 2023
Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instrumentsAndrea Horta-Barba, Saul Martinez-Horta, Jesús Pérez-Pérez, et al.
Circulation|September 1, 2020
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA TrialRenato D Lopes, Karen P Alexander, Susanna R Stevens, et al.
Chest|February 14, 2014
Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohortJuan P de Torres, Jose M Marin, Cristina Martinez-Gonzalez, et al.
Pageof 46